Wordt geladen...
Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipients
The combination of hepatitis B immune globulin with entecavir or tenofovir (at least for a certain period of time) seems to be the most reasonable prophylaxis against recurrent hepatitis B after liver transplantation. Entecavir represents an attractive option for treatment of naïve kidney transplant...
Bewaard in:
| Gepubliceerd in: | World J Gastrointest Pharmacol Ther |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Baishideng Publishing Group Inc
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4635149/ https://ncbi.nlm.nih.gov/pubmed/26558143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v6.i4.105 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|